Trial intelligence / Profile preview

High-Dose Resveratrol in Non-Diabetic Obese Males

NCT02247596Phase 2Completed

Sponsor
Khoo Teck Puat Hospital
Start
Jul 2009
Primary completion
Oct 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in obesity comparing Resveratrol with Placebo (2 arms). Primary endpoint: Resting Energy Expenditure at 2 weeks. Started Jul 2009; status: completed.

02

Drugs

resveratrol
03

Conditions

obesity

Beyond the preview

Go deeper on NCT02247596.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02247596.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call